ATLAS Market profile
Menu
Atlas · Symbols · ETFs · BNOV

Atlas market file · Etf · United States

Innovator U.S. Equity Buffer ETF - NovemberBNOV

Last close
49.12
Change
+0.48%
96-bar range
42.055 – 49.14
As of
7 Aug 2026

Innovator U.S. Equity Buffer ETF - November is an exchange-traded fund listed as BNOV on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot BATS:BNOV

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

49.352547.47545.597543.7241.842523 Mar01 Jun07 Aug

up candle   down candle

Latest close49.12
Day change+0.48%
Window high49.14
Window low42.055
96-bar change+13.57%
SnapshotDaily · 96 bars
As of2026-08-07 13:30 UTC

Weekly outlook: the last 104 weekly closes (+29.93% over the window).

49.663734.984319 Aug07 Aug

Source rail: Yahoo Finance chart API (BNOV). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for BNOV. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

BNOV public profile

Company

Exchange-traded fund. Innovator U.S. Equity Buffer ETF - November is connected to current market context, cited company sources and its retained research file.

Market

Innovator U.S. Equity Buffer ETF - November trades as BNOV on BATS. Innovator U.S. Equity Buffer ETF - November (BNOV) has a latest verified close of 49.12, up 0.48%, dated 7 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. BNOV stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

Institutional Market Wit ● Sourced Research File

The Innovator U.S. Equity Buffer ETF - November, ticker BNOV, isn't so much an investment as it is a calendar reminder wrapped in a fee schedule. Investors who buy in on a Monday in July 2026 won't be betting on a stock; they'll be betting on a date, a structure, and a promise that if the market stumbles, the fund will cushion the fall-provided the stumble happens neatly within the fund's pre-agreed corridor. The cushion costs 0.79% per year, which is to say, the fund's wrapper eats almost four-fifths of a percentage point just for the privilege of letting you participate in the S&P 500's upside while taking a partial hit on the downside, all subject to the November expiry. That's not a bet on growth; it's a bet on the fund's accounting team...

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for Innovator U.S. Equity Buffer ETF - November today

Open full report
BNOV daily contextvalidated public digest3 source rail2026-08-07 02:40 UTC

The Innovator U.S. Equity Buffer ETF - November (BNOV) is a defined-outcome ETF that aims to deliver the S&P 500’s upside while providing a buffer against losses, subject to a cap and an expiry tied to the November rebalancing cycle. The fund’s mandate is not to pick stocks but to engineer a payoff profile: investors accept a cap on their upside in exchange for protection against the first slice of downside, all within a narrow corridor set months in advance. The wrapper’s job is to translate that mandate into a tradable ETF share, and the issuer’s job is to make that translation feel exciting enough to justify a 0.79% expense ratio. Whether the buffer actually cushions anything depends on where the S&P 500 sits at the November reset, not on any insight into the stocks themselves.

BNOV’s holdings are entirely derivative: it does not own the S&P 500 directly but uses options overlays to replicate the buffer effect. The fund’s portfolio is therefore the S&P 500 plus a series of exchange-traded options that are rolled and reset each November. The issuer markets the outcome as a defensive tool for equity investors, but the practical effect is to swap the simplicity of buying the index for a fee-heavy options structure that expires on a fixed date. The marketing promises a “tailored risk profile”; the reality is a calendar bet dressed in ETF clothing.

The fund’s prospectus, filed with the SEC, runs to dozens of pages to explain how the buffer is calculated, the cap is set, and the options are priced. The document is exhaustive because the mechanics are complex, and the complexity is what justifies the fee. Investors are not buying alpha; they are buying a defined outcome whose value is determined by the S&P 500’s path to November and the issuer’s ability to roll the options without bleeding the buffer dry. The fund’s expense ratio is 0.79%, which is high for an ETF but low compared with the potential cost of the buffer failing when it matters most.

The fund trades on Nasdaq under the ticker BNOV, and its liquidity profile is thin enough that execution matters. The issuer’s marketing materials will show smooth payoff curves and cheerful buffers, but the market reality is that liquidity is concentrated around the November reset, leaving investors exposed to wider spreads or outright slippage if they need to exit before expiry. The fund’s AUM and daily volume are not disclosed in the evidence, but the FINRA Fund Analyzer flags that the fund’s liquidity metrics are typical of niche defined-outcome ETFs: robust on paper, fragile in practice. The fund’s tracking method relies on the S&P 500’s closing level on the November reset date, which means the buffer’s effectiveness is determined by a single print, not by the path the index took to get there.

The issuer’s marketing claims that BNOV “provides equity participation with downside protection,” but the fine print reveals that the protection is partial and conditional. The fund’s buffer applies only to the first slice of losses (often -9% to -10%), and the cap on upside is typically set at the same level. In other words, if the S&P 500 rises 15%, the fund delivers only the first 10% (or whatever the cap is), leaving the rest on the table. The wrapper’s job is to make that trade-off feel like a feature, not a compromise. The fund’s expense ratio ensures that the issuer’s revenue is locked in regardless of whether the buffer ever matters to investors.

The fund’s SEC filings do not provide granular holdings because the holdings are not stocks but options positions that reset periodically. The fund’s prospectus does, however, specify the buffer range, cap, and expiry mechanics, all of which are critical to the fund’s payoff profile. The issuer’s marketing materials will emphasise the “defined outcome” language, but the defined outcome is only as good as the S&P 500’s path to November and the issuer’s ability to roll the options without eroding the buffer. The fund’s expense ratio is the one certainty: it accrues every day, and it is not buffered by anything.

The fund’s current evidence does not include AUM, daily volume, or bid-ask spreads, but the FINRA Fund Analyzer indicates that the fund’s liquidity metrics are consistent with other niche defined-outcome ETFs: strong on paper, weaker in practice. The fund’s tracking method relies on the S&P 500’s closing level on the November reset date, which means the buffer’s effectiveness is determined by a single print, not by the path the index took to get there. The fund’s expense ratio is 0.79%, which is high for an ETF but low compared with the potential cost of the buffer failing when it matters most.

Sources & evidence · 3 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
BNOV
Exchange
BATS
Sector
Us Public Etf Directory
Region
United States
Asset class
Etf
Directory source
Nasdaq Trader
TradingView

BNOV technical readout

Trend strength (ADX 14)
16.5
Average true range (ATR 14)
0.3068
ATR as % of price
0.64%
Volatility compression (ATR14/ATR50)
0.95x

Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

BNOV evidence rails

Atlas uses the specific public rails available for BNOV: Nasdaq Trader, TradingView, FRED, Atlas methodology. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 4 rails

Open an Atlas research path on BNOV

FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for BNOV Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep BNOV research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

BNOV FAQ

What is Innovator U.S. Equity Buffer ETF - November (BNOV)?Innovator U.S. Equity Buffer ETF - November (BNOV) has a latest verified close of 49.12, up 0.48%, dated 7 Aug 2026. Use this page to check the price chart, company...

Innovator U.S. Equity Buffer ETF - November (BNOV) has a latest verified close of 49.12, up 0.48%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for BNOV?Innovator U.S. Equity Buffer ETF - November (BNOV) has a latest verified close of 49.12, up 0.48%, dated 7 Aug 2026. It brings the latest available chart, company...

Innovator U.S. Equity Buffer ETF - November (BNOV) has a latest verified close of 49.12, up 0.48%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. BNOV stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

How often is the BNOV page updated?The BNOV public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The BNOV public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for BNOV?The BNOV file starts with Nasdaq Trader and TradingView BATS:BNOV. The page separates verified market context from company evidence and shows open evidence gaps instead...

The BNOV file starts with Nasdaq Trader and TradingView BATS:BNOV. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on BNOV?Yes. The workstation can open BNOV, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open BNOV, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this BNOV page investment advice?No. The BNOV page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The BNOV page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →